Seven-year analysis of adjuvant pembrolizumab versus placebo in stage III melanoma in the EORTC1325 / KEYNOTE-054 trial

Paolo A. Ascierto, Alexander M.M. Eggermont, Caroline Robert, Christian U. Blank, James Larkin, Dirk Schadendorf, Matteo S. Carlino, Paul Lorigan, Susana Puig, Alexander C. J. van Akkooi, Mario Mandalà, Stefan Suciu, Victoria Atkinson, Andrew Haydon, Stéphane Dalle, Jean-Jacques Grob, Adnan Khattak, Ralf Gutzmer, Rahima Jamal, Sandrine Marréaud, Andrey Meshcheryakov, Michal Kiciński, Georgina V Long, Marye J. Boers‐Sonderen, Dmitri Grebennik, Shahneen Sandhu, Piotr Rutkowski, Anna Maria Di Giacomo, Alfonsus JM. van den Eertwegh, Clemens Kreplere

2024-09-12

SCID: 54.1/zkccp66h

Publication Details

DOI

10.1016/j.ejca.2024.114327

Publication Date

2024-09-12

Journal

Publisher

ISSN

Access Type

Author Information

Authors

Paolo A. Ascierto

Alexander M.M. Eggermont

Caroline Robert

Christian U. Blank

James Larkin

Dirk Schadendorf

Matteo S. Carlino

Paul Lorigan

Susana Puig

Alexander C. J. van Akkooi

Mario Mandalà

Stefan Suciu

Victoria Atkinson

Andrew Haydon

Stéphane Dalle

Jean-Jacques Grob

Adnan Khattak

Ralf Gutzmer

Rahima Jamal

Sandrine Marréaud

Andrey Meshcheryakov

Michal Kiciński

Georgina V Long

Marye J. Boers‐Sonderen

Dmitri Grebennik

Shahneen Sandhu

Piotr Rutkowski

Anna Maria Di Giacomo

Alfonsus JM. van den Eertwegh

Clemens Kreplere

Download PDF